| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/13/1994 | WO1994020063A3 Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof |
| 10/13/1994 | WO1994017828A3 Treatment for insulin dependent diabetes |
| 10/13/1994 | WO1994012635A3 Novel seven transmembrane receptors |
| 10/13/1994 | CA2164123A1 Gonococcal anti-idiotypic antibodies and methods and compositions using them |
| 10/13/1994 | CA2159506A1 Inhibitor of stem cell proliferation and uses thereof |
| 10/13/1994 | CA2159471A1 Cell matrix stimulated cell attachment and hemidesmosome assembly |
| 10/13/1994 | CA2159443A1 Lymphocyte activating agent |
| 10/13/1994 | CA2159359A1 Immunopotentiative and infection-protective agent, containing two or more bacillus, egg white and garlic |
| 10/13/1994 | CA2159114A1 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 10/13/1994 | CA2158554A1 Pharmaceuticals based on papillomaviruses |
| 10/13/1994 | CA2158540A1 Cloned leptospira outer membrane protein |
| 10/13/1994 | CA2158171A1 Hiv-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof |
| 10/13/1994 | CA2136973A1 Recombinant timothy grass pollen allergen ph1 pii |
| 10/13/1994 | CA2135912A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
| 10/12/1994 | EP0619117A2 Use of acemannan |
| 10/12/1994 | EP0618970A1 Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof |
| 10/12/1994 | EP0618968A1 Tools for the diagnosis and treatment of alzheimer's disease |
| 10/12/1994 | EP0618967A1 Ifn-gamma antagonist cytokine |
| 10/12/1994 | EP0618965A1 Method for generating structural and functional diversity in a peptide sequence |
| 10/12/1994 | EP0618929A1 Bispecific antibody heterodimers |
| 10/12/1994 | EP0618814A1 Recombinant bovine herpesvirus type 1 polypeptides and vaccines |
| 10/12/1994 | EP0618813A1 Antigen of hybrid m protein and carrier for group a streptococcal vaccine |
| 10/12/1994 | EP0618804A1 Peptides corresponding to antigenic determinants of htlv |
| 10/12/1994 | EP0546099B1 Use of human Interferon gamma 4-134 |
| 10/12/1994 | EP0494294B1 Bacterial stress proteins |
| 10/12/1994 | EP0434713B1 Hiv-1 envelope muteins lacking hypervariable domains |
| 10/12/1994 | CN1093255A Vaccines against sterols |
| 10/11/1994 | US5354853 Phospholipid-saccharide conjugates |
| 10/11/1994 | US5354848 Producing simple or substituted carbamylic amino groups, or substituted thiocarbamylic amino groups or substituted guanidino groups; hyposensitizing therapy |
| 10/11/1994 | US5354847 Chimeric antibody with specificity to human tumor antigen |
| 10/11/1994 | US5354765 Synergistic |
| 10/11/1994 | US5354693 Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassy |
| 10/11/1994 | US5354691 Immunogens inducing resistance to autoimmune arthritis |
| 10/11/1994 | US5354674 Method of gene transfer using retrotransposons |
| 10/11/1994 | US5354665 Recombinant DNA processes for producing PI-linked lymphocyte function associated antigen-3 |
| 10/11/1994 | US5354659 Method for detecting pathological pregnancy |
| 10/11/1994 | US5354555 Against Infectious Hematopoietic Necrosis virus |
| 10/11/1994 | CA1332367C Method for the reduction of heterogeneity of monoclonal antibodies |
| 10/11/1994 | CA1332366C Leukotoxin gene of pasteurella haemolytica |
| 10/06/1994 | DE4410136A1 Tumoricidal T lymphocytes |
| 10/05/1994 | EP0618448A1 Method to detect bone and other connective tissue disorders in humans and animals |
| 10/05/1994 | EP0618292A1 CEA derivatives lacking the Hydrophobic C-terminal domain |
| 10/05/1994 | EP0618231A1 Immunologically active conjugates and a method for their preparation |
| 10/04/1994 | US5352670 Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides |
| 10/04/1994 | US5352587 Genetic engineering |
| 10/04/1994 | US5352576 Method of determining the presence and titers of anti HIV-1 ag27bodies |
| 10/04/1994 | US5352575 Pseudorabies virus protein |
| 10/04/1994 | US5352462 Presents in whey of pasteurized skimmed milk both in aggregate and nonaggregate form, free of peptide or protein, binds to chromatography medium, not inactivated by boiling |
| 10/04/1994 | US5352450 Method for preparing vaccine for dental caries and vaccinal compositions for dental caries used as nasal drop |
| 10/04/1994 | US5352449 Vaccine comprising recombinant feline leukemia antigen and saponin adjuvant |
| 10/04/1994 | US5352446 Applying antibodies to tooth surfaces |
| 10/01/1994 | CA2119733A1 Antibody-drug conjugates |
| 09/29/1994 | WO1994022014A1 Parvovirus receptors and methods of use |
| 09/29/1994 | WO1994021812A2 Hepatitis b escape mutant specific binding molecules |
| 09/29/1994 | WO1994021808A1 Process for preparing cancer vaccines |
| 09/29/1994 | WO1994021807A2 Defective mutant non-retroviral virus (e.g. hsv) as vaccine |
| 09/29/1994 | WO1994021800A2 Protein tyrosine phosphatase ptp-s31 |
| 09/29/1994 | WO1994021799A1 USE OF PORCINE GAL α(1,3) GALACTOSYL TRANSFERASE IN XENOGRAFT THERAPIES |
| 09/29/1994 | WO1994021798A1 Stimulation of immune response by viral protein |
| 09/29/1994 | WO1994021797A1 Nucleic acid pharmaceuticals |
| 09/29/1994 | WO1994021792A2 Inhibition of selected tumor growth with recombinant viral vectors |
| 09/29/1994 | WO1994021781A2 Extracellular signal-regulated kinase, sequences, and methods of production and use |
| 09/29/1994 | WO1994021685A1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
| 09/29/1994 | WO1994021684A1 Botulinum toxin polypeptides and their use as vaccine enhancing agents |
| 09/29/1994 | WO1994021680A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 09/29/1994 | WO1994021672A1 Novel antimicrobial peptides from bovine neutrophils |
| 09/29/1994 | WO1994021656A2 Novel phospholipid-saccharide conjugates |
| 09/29/1994 | WO1994021298A1 Stabilised pharmaceutical compositions and methods for preparing same |
| 09/29/1994 | WO1994021297A1 Recognin vaccines |
| 09/29/1994 | WO1994021295A1 Methods for inhibiting hiv associated disease using monoclonal antibodies directed against anti-self cytotoxic t-cells |
| 09/29/1994 | WO1994021292A1 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| 09/29/1994 | WO1994021291A1 Chlamydia vaccine and process |
| 09/29/1994 | WO1994021290A1 High molecular weight surface proteins of non-typeable haemophilus |
| 09/29/1994 | WO1994021289A1 Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres |
| 09/29/1994 | WO1994021288A1 Composition and method for reducing toxicity of biologically-active factors |
| 09/29/1994 | WO1994021287A1 Peptide coated dendritic cells as immunogens |
| 09/29/1994 | WO1994021284A1 Therapeutic formulation and method |
| 09/29/1994 | WO1994021281A1 Polymer-polypeptide composition and method |
| 09/29/1994 | WO1994021240A2 Superparamagnetic particles, process for producing the same and their use |
| 09/29/1994 | WO1994021235A1 Enhanced circulation effector composition and method |
| 09/29/1994 | WO1994016094A3 Recombinant anti-vla4 antibody molecules |
| 09/29/1994 | WO1994014967A3 Cs31a protein capsule subunit modified by at least one heterologous peptide, cs31a protein capsule comprising said subunit, micro-organisms having such subunits on their outer membrane, and methods for preparing and using same |
| 09/29/1994 | WO1994011522A3 Vector for the expression of therapy-relevant genes |
| 09/29/1994 | WO1994011490A3 Products of the inhibition of advanced glycosylation |
| 09/29/1994 | CA2158939A1 Protein tyrosine phosphatase ptp-s31 |
| 09/29/1994 | CA2158866A1 Hepatitis b escape mutant specific binding molecules |
| 09/29/1994 | CA2158748A1 Botulinum toxin polypeptides and their use as vaccine enhancing agents |
| 09/29/1994 | CA2158658A1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
| 09/29/1994 | CA2158655A1 Process for preparing cancer vaccines |
| 09/29/1994 | CA2158564A1 Parvovirus receptors and methods of use |
| 09/29/1994 | CA2158546A1 Inhibition of selected tumor growth with recombinant viral vectors |
| 09/29/1994 | CA2158461A1 Stimulation of immune response by viral protein |
| 09/29/1994 | CA2158281A1 Peptide coated dendritic cells as immunogens |
| 09/29/1994 | CA2158148A1 Defective mutant non-retroviral virus (e.g. hsv) as vaccine |
| 09/29/1994 | CA2158140A1 Stabilized pharmaceutical compositions and methods for preparing same |
| 09/29/1994 | CA2158055A1 Novel phospholipid-saccharide conjugates |
| 09/29/1994 | CA2155739A1 Novel antimicrobial peptides from bovine neutrophils |
| 09/28/1994 | EP0617128A1 Recombinant vaccine for porcine pleuropneumonia |
| 09/28/1994 | EP0617127A1 Antigenic epitopes on B cell-bound IgE Immunoglobulins |
| 09/28/1994 | EP0617125A2 A novel transport protein gene from the Huntington's disease region |